Topic: Pharma sector
Guidelines for evaluation of Nano Pharmaceuticals released
Ministry of Science and Technology issued the “Guidelines for the Evaluation of Nano pharmaceuticals in India” on October 24, 2019. This is the most crucial step for delineating...
India to add 3 Million Tech Jobs by 2023: ISF
According to Indian Staffing Federation’s (ISF) Tech Employment Projections, the Indian tech industry will add another three million new jobs in next 5 years. Key Highlights With the...
Health Ministry releases draft rules for e-pharmacies to regulate online sale of medicines
Union Health Ministry has released draft rules on sale of drugs by e-pharmacies to regulate online sale of medicines across India. These rules also have been proposed to...
Indian Pharmacopoeia Commission approves modern animal-free testing for drugs
Indian Pharmacopoeia Commission (IPC) has in its 2018 edition of Indian Pharmacopoeia approved modern, animal-free tests for drug manufacturers. It will spare animals from suffering due to drug...
NPPA fixes retail price of 30 drug formulations
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed retail price for 30 drug formulations, including those used for treatment of diabetes, bacterial infections and high blood...
Two Experimental Ebola vaccines found safe, effective in human trial
The clinical trials of two experimental Ebola vaccines cAd3-EBOZ and rVSV-ZEBOV were found to be safe and capable of eliciting immune response against Ebola virus that lasts for... Government constitute committee to make drugs more affordable
The Union Ministry of Chemicals and Fertilisers has constituted a committee of joint secretaries for ensuring enhanced affordability, availability and accessibility of drugs for the citizens. The committee...
NRAI gets highest WHO ratings for vaccine regulations
India’s vaccine regulatory body NRAI (National Regulatory Authority of India) was given the maximum ratings by the World Health Organisation (WHO) for vaccine regulations. The ratings were given... DTAB suggests one-time licensing for drugs
The Drugs Technical Advisory Board (DTAB) recently recommended one-time licensing for manufacture and sales of drugs. If the recommendation is approved it will change present of the renewal... Delhi High Court reverses ban on fixed dose combination drugs
The Delhi High Court has quashed ban imposed on 344 fixed dose combination (FDC) drugs by the Central Government over fears that they are potential health and safety...
WHO settles India, EU medicine dispute issue
The World Health Organisation (WHO) has dropped the term ‘counterfeit’ and retained ‘falsified’ to describe medicines of inferior quality. This decision was taken by a WHO’s technical working... 